Published in Nat Rev Cardiol on March 29, 2011
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med (2011) 11.11
Characterization of mice lacking the gene for cholecystokinin. Am J Physiol Regul Integr Comp Physiol (2007) 1.09
Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts. J Neuroimmunol (2007) 1.01
Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology (2010) 0.89
Lipids. Antibodies against PCSK9--a new era of therapy. Nat Rev Cardiol (2012) 0.89
Public health: Health risks of physical inactivity similar to smoking. Nat Rev Cardiol (2012) 0.88
Stem cells. Could it be TIME to abandon BMCs? Nat Rev Cardiol (2012) 0.87
Tumor O(6)-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib. Clin Cancer Res (2010) 0.85
Children are key to CVD prevention. Nat Rev Cardiol (2010) 0.79
Acute coronary syndromes: ACS in developing countries--insights from the ACCESS registry. Nat Rev Cardiol (2011) 0.78
Public health: Value of echocardiographic screening for RHD in Ugandan children. Nat Rev Cardiol (2012) 0.78
Erectile dysfunction and CVD. Nat Rev Cardiol (2010) 0.77
Prevention: Neuropsychiatric adverse effects signal the end of the line for rimonabant. Nat Rev Cardiol (2010) 0.77
Poor health literacy: a 'hidden' risk factor. Nat Rev Cardiol (2010) 0.77
Elevated systolic blood pressure in middle age is associated with late-life dementia. Nat Rev Cardiol (2010) 0.75
Valvular disease: TAVR outcomes maintained 2-years after the PARTNER trial. Nat Rev Cardiol (2012) 0.75
Atrial fibrillation. First-line catheter ablation therapy--too much too soon? Nat Rev Cardiol (2012) 0.75
Congenital heart conditions. Closure of PFO--more questions than answers. Nat Rev Cardiol (2013) 0.75
Prevention: Low-dose omega-3 supplementation--no beneficial effect in patients with prior MI. Nat Rev Cardiol (2010) 0.75
Heart failure: Registry data reveal disparities in care. Nat Rev Cardiol (2012) 0.75
Vascular disease: Atherosclerosis unravelled--clues from ancient civilizations. Nat Rev Cardiol (2013) 0.75
Arrhythmias. A new hybrid ablation technique for AF. Nat Rev Cardiol (2011) 0.75
Coronary artery disease: individualize care for multivessel CAD. Nat Rev Cardiol (2013) 0.75
Heart failure: Placing an EMPHASIS on the mineralocorticoid receptor--benefit of eplerenone in mild HF. Nat Rev Cardiol (2011) 0.75
Risk factors: Cigarette smoking increases the risk of coronary heart disease in women more than in men. Nat Rev Cardiol (2011) 0.75
Acute coronary syndromes: Abciximab delivered to the MI lesion reduces infarct size. Nat Rev Cardiol (2012) 0.75
Advanced age should not be a contraindication for cardiac resynchronization therapy. Nat Rev Cardiol (2012) 0.75
Device therapy: Reuse of ICDs in developing countries--'proof of concept' data published. Nat Rev Cardiol (2012) 0.75
Risk factors: Eating for two? Maternal weight gain and offspring cardiovascular risk. Nat Rev Cardiol (2010) 0.75
Acute coronary syndromes: Is early abciximab beneficial in STEMI? Nat Rev Cardiol (2012) 0.75
Interventional cardiology: Examining the issues related to PCI without on-site surgical back-up. Nat Rev Cardiol (2012) 0.75
Risk factors: Everything in moderation—binge drinking increases CVD risk. Nat Rev Cardiol (2011) 0.75
Thrombosis: Choose thigh-length compression stockings for DVT prevention. Nat Rev Cardiol (2010) 0.75
Atrial fibrillation: Is dabigatran cost-effective compared with warfarin in patients with AF? Nat Rev Cardiol (2011) 0.75
Hypertension: Understanding patients' perceptions could improve therapy. Nat Rev Cardiol (2012) 0.75
Interventional cardiology: Cormorbidity index could help select elderly patients for SES implantation. Nat Rev Cardiol (2011) 0.75
The dual challenge of BP control. Nat Rev Cardiol (2009) 0.75
Arrhythmias: Widespread use of public-access AEDs improves survival after cardiac arrest. Nat Rev Cardiol (2010) 0.75
Atrial fibrillation: new-onset AF in women--an independent risk factor or a 'canary in a coal mine'? Nat Rev Cardiol (2011) 0.75
Arrhythmias: CPAP with ablation reduces AF in OSA. Nat Rev Cardiol (2013) 0.75
Surgery: COPPS trial heralds new indication for colchicine. Nat Rev Cardiol (2010) 0.75
Antiplatelet therapy: Surgery should not interrupt treatment. Nat Rev Cardiol (2011) 0.75
Cardiomyopathies: CMR sheds new light on the clinical profile of stress cardiomyopathy. Nat Rev Cardiol (2011) 0.75
Coronary artery disease: CABG is preferable to PCI for complex left-main or three-vessel disease. Nat Rev Cardiol (2011) 0.75
Prevention. Cost-effectiveness of cardiovascular disease prevention and management in the developing world. Nat Rev Cardiol (2012) 0.75
Heart failure: Registry data highlight global differences in care for HF-PEF. Nat Rev Cardiol (2011) 0.75
Erectile dysfunction and CVD. Nat Rev Urol (2010) 0.75
Prevention: Fibrates reduce risk of coronary events. Nat Rev Cardiol (2010) 0.75
Prevention: the benefits of a Mediterranean diet. Nat Rev Cardiol (2013) 0.75
Arrhythmias: apixaban triumphs over aspirin for stroke prevention in patients with atrial fibrillation. Nat Rev Cardiol (2011) 0.75
Surgery: No benefit of cerebral perfusion over hypothermia in pulmonary endarterectomy. Nat Rev Cardiol (2011) 0.75
Risk factors: Fried foods not linked to CHD in Spain. Nat Rev Cardiol (2012) 0.75
Hypertension: Careful monitoring of kidney function is needed in patients with hypertension. Nat Rev Cardiol (2010) 0.75
Eptifibatide is noninferior to abciximab: implications for clinical practice. Nat Rev Cardiol (2010) 0.75
Cyclosporine after MI. Nat Rev Cardiol (2010) 0.75
Prevention: Statins go beyond cardioprotection. Nat Rev Cardiol (2011) 0.75
Atrial fibrillation: Could subclinical AF be a missing link in the etiology of cryptogenic stroke? Nat Rev Cardiol (2012) 0.75
Heart failure: TITAN trial results published. Nat Rev Cardiol (2012) 0.75
Imaging cerebral microemboli during TAVI. Nat Rev Cardiol (2012) 0.75
Arrhythmias: home AEDs-a question of rhythm? Nat Rev Cardiol (2011) 0.75
Stroke: parental stroke is an independent risk factor for stroke and transient ischemic attack. Nat Rev Cardiol (2010) 0.75
Surgery: radial artery grafts not superior to saphenous vein grafts at 1 year after CABG surgery. Nat Rev Cardiol (2011) 0.75
Thrombosis: Selective D-dimer testing improves efficiency of DVT diagnosis. Nat Rev Cardiol (2013) 0.75
Valvular disease: the UK TAVI experience: insights from the 'real world'. Nat Rev Cardiol (2011) 0.75
Diagnosis. Novel protocol for risk assessment of patients with chest pain. Nat Rev Cardiol (2011) 0.75
Heart failure: poor health literacy increases mortality. Nat Rev Cardiol (2011) 0.75
Valvular disease: PARTNER cohort A-TAVR is an option for operable severe aortic stenosis. Nat Rev Cardiol (2011) 0.75
Heart failure. Promising data for serelaxin. Nat Rev Cardiol (2012) 0.75
Interventional cardiology: Radial access improves PCI outcomes. Nat Rev Cardiol (2012) 0.75
Interventional cardiology: New insights into PCI for chronic total occlusion. Nat Rev Cardiol (2012) 0.75
Novel omega-3 agent reduces residually high triglyceride levels in patients treated with statins. Nat Rev Cardiol (2012) 0.75
Vascular disease: aortic plaque--dual therapy for a heterogeneous disease. Nat Rev Cardiol (2013) 0.75
Atrial fibrillation: First head-to-head comparison of catheter and surgical ablation for drug-refractory AF. Nat Rev Cardiol (2011) 0.75
Air pollution reduces EPC levels. Nat Rev Cardiol (2010) 0.75
Interventional cardiology. Radial artery access--a RIVAL to the femoral approach. Nat Rev Cardiol (2011) 0.75
Device therapy: avoid apical lead position in CRT. Nat Rev Cardiol (2011) 0.75
Congenital heart conditions: Clear benefits of pulse oximetry in neonates--one small step to improving postnatal cardiac care. Nat Rev Cardiol (2011) 0.75
Risk factors: Pregnancy loss increases risk of MI. Nat Rev Cardiol (2011) 0.75
Arrhythmias: RAAS inhibition in atrial fibrillation-one strike, but not out? Nat Rev Cardiol (2011) 0.75
Lipids: Cardioprotective effects of HDL cholesterol called into question. Nat Rev Cardiol (2012) 0.75
Obesity: long-term benefits of gastric bypass on cardiac structure and function. Nat Rev Cardiol (2011) 0.75
Prevention: Small reductions in risk factors equal big savings in health-care costs. Nat Rev Cardiol (2011) 0.75
Arrhythmias. Ablation of atrioventricular nodal re-entrant tachycardia is safe and effective in the elderly. Nat Rev Cardiol (2011) 0.75
Arrhythmias: High-dose, prescription omega-3 fatty acids do not prevent recurrent AF. Nat Rev Cardiol (2011) 0.75
Coronary heart disease: New hope for CETP inhibitors. Nat Rev Cardiol (2011) 0.75
Hypertension: AT1 autoantibodies and response to therapy. Nat Rev Cardiol (2011) 0.75
Antiplatelet therapy: Making the SWAP from clopidrogrel to prasugrel. Nat Rev Cardiol (2010) 0.75
Digital technology in cardiac care. Nat Rev Cardiol (2010) 0.75
Atrial fibrillation: RF needle improves septal puncture. Nat Rev Cardiol (2011) 0.75
Acute coronary syndromes: Air pollution and survival after MI. Nat Rev Cardiol (2013) 0.75
Prevention. Statin therapy--if at first you don't succeed... Nat Rev Cardiol (2013) 0.75
Interventional cardiology: Antithrombotic therapy for PCI--getting the balance right. Nat Rev Cardiol (2013) 0.75
Prevention. Low adoption of healthy lifestyles. Nat Rev Cardiol (2013) 0.75
Device therapy: Clinical sequelae of cardiac device-related endocarditis. Nat Rev Cardiol (2012) 0.75
Thrombosis: An effective therapy for leg SVT. Nat Rev Cardiol (2010) 0.75
Atrial fibrillation: HAS-BLED--a new risk score to predict bleeding in patients with AF. Nat Rev Cardiol (2011) 0.75
Cardiac resuscitation: Optimum CPR strategies clarified. Nat Rev Cardiol (2011) 0.75
Atrial fibrillation: Is short-term antiarrhythmic therapy an option? Nat Rev Cardiol (2012) 0.75
Atrial fibrillation: Strict rate control unnecessary in AF? Nat Rev Cardiol (2011) 0.75
Vascular disease. Corticosteroid therapy improves outcomes for Japanese children with Kawasaki disease. Nat Rev Cardiol (2012) 0.75
Prevention: could flu vaccine join the secondary prevention armamentarium for ACS? Nat Rev Cardiol (2011) 0.75